252 related articles for article (PubMed ID: 22826888)
1. Delivery of antigens used for vaccination: recent advances and challenges.
Scherliess R
Ther Deliv; 2011 Oct; 2(10):1351-68. PubMed ID: 22826888
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery.
Babiuk S; Baca-Estrada M; Babiuk LA; Ewen C; Foldvari M
J Control Release; 2000 May; 66(2-3):199-214. PubMed ID: 10742580
[TBL] [Abstract][Full Text] [Related]
3. Nanocarriers: a versatile approach for mucosal vaccine delivery.
Mody N; Sharma R; Agrawal U; Vyas SP
Ther Deliv; 2015 Feb; 6(2):231-45. PubMed ID: 25690089
[TBL] [Abstract][Full Text] [Related]
4. [New routes of administration: epidermal, transcutaneous mucosal ways of vaccination].
Denis F; Alain S; Ploy MC
Med Sci (Paris); 2007 Apr; 23(4):379-85. PubMed ID: 17433227
[TBL] [Abstract][Full Text] [Related]
5. Utilizing Salmonella for antigen delivery: the aims and benefits of bacterial delivered vaccination.
Kong W; Clark-Curtiss J; Curtiss R
Expert Rev Vaccines; 2013 Apr; 12(4):345-7. PubMed ID: 23560914
[No Abstract] [Full Text] [Related]
6. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
De Magistris MT
Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
[TBL] [Abstract][Full Text] [Related]
7. Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery.
Wang SH; Thompson AL; Hickey AJ; Staats HF
Curr Top Microbiol Immunol; 2012; 354():121-56. PubMed ID: 21822816
[TBL] [Abstract][Full Text] [Related]
8. Dissolving Microneedle Patches for Dermal Vaccination.
Leone M; Mönkäre J; Bouwstra JA; Kersten G
Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
[TBL] [Abstract][Full Text] [Related]
9. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
[TBL] [Abstract][Full Text] [Related]
10. Delivery strategies to enhance oral vaccination against enteric infections.
Davitt CJ; Lavelle EC
Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
[TBL] [Abstract][Full Text] [Related]
11. Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.
Matsuo K; Hirobe S; Okada N; Nakagawa S
Vaccine; 2013 May; 31(19):2403-15. PubMed ID: 23523401
[TBL] [Abstract][Full Text] [Related]
12. Microneedles for vaccine delivery: challenges and future perspectives.
Shin CI; Jeong SD; Rejinold NS; Kim YC
Ther Deliv; 2017 Jun; 8(6):447-460. PubMed ID: 28530151
[TBL] [Abstract][Full Text] [Related]
13. Nasal vaccine innovation.
Jabbal-Gill I
J Drug Target; 2010 Dec; 18(10):771-86. PubMed ID: 21047271
[TBL] [Abstract][Full Text] [Related]
14. Potential use of microarray patches for vaccine delivery in low- and middle- income countries.
Peyraud N; Zehrung D; Jarrahian C; Frivold C; Orubu T; Giersing B
Vaccine; 2019 Jul; 37(32):4427-4434. PubMed ID: 31262587
[TBL] [Abstract][Full Text] [Related]
15. Single-injection vaccines: Progress, challenges, and opportunities.
McHugh KJ; Guarecuco R; Langer R; Jaklenec A
J Control Release; 2015 Dec; 219():596-609. PubMed ID: 26254198
[TBL] [Abstract][Full Text] [Related]
16. Gut-associated lymphoid tissues for the development of oral vaccines.
Kunisawa J; Kurashima Y; Kiyono H
Adv Drug Deliv Rev; 2012 May; 64(6):523-30. PubMed ID: 21827802
[TBL] [Abstract][Full Text] [Related]
17. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
[TBL] [Abstract][Full Text] [Related]
18. Transcutaneous vaccines--current and emerging strategies.
Hirobe S; Okada N; Nakagawa S
Expert Opin Drug Deliv; 2013 Apr; 10(4):485-98. PubMed ID: 23316778
[TBL] [Abstract][Full Text] [Related]
19. Delivery strategies to enhance mucosal vaccination.
Chadwick S; Kriegel C; Amiji M
Expert Opin Biol Ther; 2009 Apr; 9(4):427-40. PubMed ID: 19344280
[TBL] [Abstract][Full Text] [Related]
20. New insights in mucosal vaccine development.
Pavot V; Rochereau N; Genin C; Verrier B; Paul S
Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]